Multiplex protein assays allow multiple targets quantification in a single sample, a bit like performing up to 40 different ELISAs in one go. Outsourcing Multiplex Protein Quantification projects to experts may work out more cost effective and time saving. It saves you the hassle of setting up a new technology in your lab, and you can rely on people with years of expertise in the technology to generate quality data on the very first run. Should you wish to set it up in your own lab, some technologies are easily adaptable if you have access to the equipment.
The global Protein Multiplex Assays market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Protein Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Protein Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Protein Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Protein Multiplex Assays include Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abcam, Becton, Dickinson and Company, Merck KGaA and Agilent Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Protein Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Multiplex Assays.
Report Scope
The Protein Multiplex Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Protein Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Protein Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Segment by Type
Planar Protein Assays
Bead-Based Protein Assays
Other Protein Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Protein Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Protein Multiplex Assays Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Planar Protein Assays
1.2.3 Bead-Based Protein Assays
1.2.4 Other Protein Assays
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Protein Multiplex Assays Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Protein Multiplex Assays Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Protein Multiplex Assays Growth Trends by Region
2.2.1 Global Protein Multiplex Assays Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Protein Multiplex Assays Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Protein Multiplex Assays Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Protein Multiplex Assays Âé¶¹Ô´´ Dynamics
2.3.1 Protein Multiplex Assays Industry Trends
2.3.2 Protein Multiplex Assays Âé¶¹Ô´´ Drivers
2.3.3 Protein Multiplex Assays Âé¶¹Ô´´ Challenges
2.3.4 Protein Multiplex Assays Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Protein Multiplex Assays Players by Revenue
3.1.1 Global Top Protein Multiplex Assays Players by Revenue (2019-2024)
3.1.2 Global Protein Multiplex Assays Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Protein Multiplex Assays Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Protein Multiplex Assays Revenue
3.4 Global Protein Multiplex Assays Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Protein Multiplex Assays Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein Multiplex Assays Revenue in 2023
3.5 Protein Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Protein Multiplex Assays Product Solution and Service
3.7 Date of Enter into Protein Multiplex Assays Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Multiplex Assays Breakdown Data by Type
4.1 Global Protein Multiplex Assays Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Protein Multiplex Assays Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Protein Multiplex Assays Breakdown Data by Application
5.1 Global Protein Multiplex Assays Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Protein Multiplex Assays Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Protein Multiplex Assays Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Protein Multiplex Assays Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Protein Multiplex Assays Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Protein Multiplex Assays Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Protein Multiplex Assays Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Protein Multiplex Assays Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Protein Multiplex Assays Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Protein Multiplex Assays Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Protein Multiplex Assays Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Protein Multiplex Assays Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Protein Multiplex Assays Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Protein Multiplex Assays Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Protein Multiplex Assays Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Protein Multiplex Assays Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Protein Multiplex Assays Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Protein Multiplex Assays Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Protein Multiplex Assays Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Protein Multiplex Assays Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Protein Multiplex Assays Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Protein Multiplex Assays Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luminex Corporation
11.1.1 Luminex Corporation Company Detail
11.1.2 Luminex Corporation Business Overview
11.1.3 Luminex Corporation Protein Multiplex Assays Introduction
11.1.4 Luminex Corporation Revenue in Protein Multiplex Assays Business (2019-2024)
11.1.5 Luminex Corporation Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Protein Multiplex Assays Introduction
11.2.4 Thermo Fisher Scientific Revenue in Protein Multiplex Assays Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Protein Multiplex Assays Introduction
11.3.4 Bio-Rad Laboratories Revenue in Protein Multiplex Assays Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Protein Multiplex Assays Introduction
11.4.4 Qiagen Revenue in Protein Multiplex Assays Business (2019-2024)
11.4.5 Qiagen Recent Development
11.5 Abcam
11.5.1 Abcam Company Detail
11.5.2 Abcam Business Overview
11.5.3 Abcam Protein Multiplex Assays Introduction
11.5.4 Abcam Revenue in Protein Multiplex Assays Business (2019-2024)
11.5.5 Abcam Recent Development
11.6 Becton
11.6.1 Becton Company Detail
11.6.2 Becton Business Overview
11.6.3 Becton Protein Multiplex Assays Introduction
11.6.4 Becton Revenue in Protein Multiplex Assays Business (2019-2024)
11.6.5 Becton Recent Development
11.7 Dickinson and Company
11.7.1 Dickinson and Company Company Detail
11.7.2 Dickinson and Company Business Overview
11.7.3 Dickinson and Company Protein Multiplex Assays Introduction
11.7.4 Dickinson and Company Revenue in Protein Multiplex Assays Business (2019-2024)
11.7.5 Dickinson and Company Recent Development
11.8 Merck KGaA
11.8.1 Merck KGaA Company Detail
11.8.2 Merck KGaA Business Overview
11.8.3 Merck KGaA Protein Multiplex Assays Introduction
11.8.4 Merck KGaA Revenue in Protein Multiplex Assays Business (2019-2024)
11.8.5 Merck KGaA Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Protein Multiplex Assays Introduction
11.9.4 Agilent Technologies Revenue in Protein Multiplex Assays Business (2019-2024)
11.9.5 Agilent Technologies Recent Development
11.10 Bio-Techne
11.10.1 Bio-Techne Company Detail
11.10.2 Bio-Techne Business Overview
11.10.3 Bio-Techne Protein Multiplex Assays Introduction
11.10.4 Bio-Techne Revenue in Protein Multiplex Assays Business (2019-2024)
11.10.5 Bio-Techne Recent Development
11.11 Shimadzu Biotech
11.11.1 Shimadzu Biotech Company Detail
11.11.2 Shimadzu Biotech Business Overview
11.11.3 Shimadzu Biotech Protein Multiplex Assays Introduction
11.11.4 Shimadzu Biotech Revenue in Protein Multiplex Assays Business (2019-2024)
11.11.5 Shimadzu Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Ìý
Ìý
*If Applicable.